Berlin - Delayed Quote EUR

Tiziana Life Sciences Ltd (0RP.BE)

1.2400
+0.0200
+(1.64%)
At close: June 6 at 9:40:05 PM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Cost of Revenue
0
--
--
--
0
Gross Profit
0
--
--
--
0
Operating Expense
15,794
15,794
17,984
14,586
27,374
Operating Income
-15,794
-15,794
-17,984
-14,586
-27,374
Net Non Operating Interest Income Expense
808
808
1,144
-6
-176
Other Income Expense
-1,760
-1,760
-402
-804
893
Pretax Income
-16,746
-16,746
-17,242
-15,397
-26,657
Tax Provision
-4,883
-4,883
449
0
-3,240
Net Income Common Stockholders
-11,863
-11,863
-17,691
-15,397
-23,417
Diluted NI Available to Com Stockholders
-11,863
-11,863
-17,691
-15,397
-23,417
Basic EPS
-0.11
--
-0.17
-0.15
-0.24
Diluted EPS
-0.11
--
-0.17
-0.15
-0.24
Basic Average Shares
106,672.3420
--
102,471.0160
101,526.3890
97,932.0550
Diluted Average Shares
106,672.3420
--
102,471.0160
101,526.3890
97,932.0550
Total Operating Income as Reported
-15,794
-15,794
-17,984
-14,586
-27,374
Total Expenses
15,794
15,794
17,984
14,586
27,374
Net Income from Continuing & Discontinued Operation
-11,863
-11,863
-17,691
-15,397
-23,417
Normalized Income
-10,616.2020
-10,616.2020
-17,373.4200
-14,528
-23,417
Interest Income
814
814
1,154
32
0
Interest Expense
6
6
10
38
176
Net Interest Income
808
808
1,144
-6
-176
EBIT
-16,740
-16,740
-17,232
-15,359
-26,481
EBITDA
-16,616
-16,616
-17,136
-15,308
-26,340
Reconciled Cost of Revenue
0
--
--
--
0
Reconciled Depreciation
124
124
96
51
141
Net Income from Continuing Operation Net Minority Interest
-11,863
-11,863
-17,691
-15,397
-23,417
Total Unusual Items Excluding Goodwill
-1,760
-1,760
-402
-869
0
Total Unusual Items
-1,760
-1,760
-402
-869
0
Normalized EBITDA
-14,856
-14,856
-16,734
-14,439
-26,340
Tax Rate for Calcs
0.0003
0.0003
0.0002
0
0.0001
Tax Effect of Unusual Items
-513.2020
-513.2020
-84.4200
0
0
12/31/2021 - 3/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade